CD200 Promotes Gastric Cancer Progression and Metastasis by Inducing the β‐catenin Signaling Pathway
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Hana Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biological Sciences & BK 21 FOUR Educational Research Group for Age-associated Disorder Control Technology, Chosun Universi…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Antigens, CD, beta Catenin, Wnt Signaling Pathway. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer‐related mortalities worldwide. Understanding the mechanisms driving tumor growth and metastasis in gastric cancer is essential for the development of effective therapeutic strategies. In this regard, it is well‐established that CD200, a glycoprotein that binds to the CD200 receptor, has notable immunosuppressive effects. The extracellular domain of CD200 is secreted into the tumor microenvironment (TME), wherein it promotes cancer progression. However, although CD200 is highly expressed in several types of cancers, the details of its intracellular roles in tumor progression remain poorly understood. In this study, we investigated the biological function and mechanism of action of CD200 in gastric cancer. Public datasets from GSE and TCGA revealed that CD200 is overexpressed in gastric cancer and that its expression is correlated with cancer stage and metastasis. Functionally, we found that CD200 enhances cell proliferation, migration, and invasion, and also promotes the expression of epithelial‐mesenchymal transition (EMT)‐related genes. Mechanistically, CD200 was demonstrated activate the WNT/β‐catenin signaling pathway by inducing β‐catenin activation. Notably, we established that the cytoplasmic domain of CD200 binds directly to β‐catenin, thereby facilitating its nuclear translocation. The CD200/β‐catenin/TCF4 complex subsequently promotes the transcription of β‐catenin target and EMT‐related genes. Collectively, our findings in this study revealed that the cytoplasmic domain of CD200 interacts with β‐catenin, thereby promoting the transcriptional activation of β‐catenin target genes and inducing tumor growth and metastasis in gastric cancer. These findings accordingly indicate that CD200 may serve as a potential therapeutic target for the treatment of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biological Sciences & BK 21 FOUR Educational Research Group for Age-associated Disorder Control Technology, Chosun University, Gwangju, Republic of Korea.
- Institute of Well-Aging Medicare & Chosun University G-LAMP Project group, Chosun University, Gwangju, Republic of Korea.
- Bio R&D center, Samsung biologics, Incheon, Republic of Korea.
- Department of Biomedical Science, Chosun University, Gwangju, Republic of Korea.
ORCID-Profile: Seok-Jun Kim
Zitieren
APA
Lee, H., Bae, J. M., Shin, S. P., Kim, W., Kim, W. J., Kang, H. G., Choi, D. B., Lee, Y. S., & Kim, S. J. (2025). CD200 Promotes Gastric Cancer Progression and Metastasis by Inducing the β‐catenin Signaling Pathway. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70101
Vancouver
Lee H, Bae JM, Shin SP, Kim W, Kim WJ, Kang HG, et al. CD200 Promotes Gastric Cancer Progression and Metastasis by Inducing the β‐catenin Signaling Pathway. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70101
BibTeX
@article{Lee2025,
author = {Lee, Hana and Bae, Jang-Mi and Shin, Seung-Phil and Kim, Woong and Kim, Won-Jin and Kang, Hyeon-Gu and Choi, Da-Bin and Lee, Yu-Seon and Kim, Seok-Jun},
title = {CD200 Promotes Gastric Cancer Progression and Metastasis by Inducing the β‐catenin Signaling Pathway},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.70101}
}
EUVIMED